112 related articles for article (PubMed ID: 6095483)
1. Succinate potentiates the action of platelet agonists.
Huang EM; McGowan EB; Detwiler TC
Thromb Res; 1984 Oct; 36(1):1-8. PubMed ID: 6095483
[TBL] [Abstract][Full Text] [Related]
2. Regulation of human platelet activation--analysis of cyclooxygenase and cyclic AMP-dependent pathways.
Krishnamurthi S; Westwick J; Kakkar VV
Biochem Pharmacol; 1984 Oct; 33(19):3025-35. PubMed ID: 6091666
[TBL] [Abstract][Full Text] [Related]
3. Prostacyclin potentiates 13-azaprostanoic acid-induced platelet deaggregation.
Parise LV; Venton DL; Le Breton GC
Thromb Res; 1982 Dec; 28(6):721-30. PubMed ID: 6301090
[TBL] [Abstract][Full Text] [Related]
4. The potentiation of phorbol ester-induced aggregation of human platelets by the prostaglandin endoperoxide analogue, U46619.
Edwards MC; Williamson EM; Evans FJ
J Pharm Pharmacol; 1987 May; 39(5):370-7. PubMed ID: 2886585
[TBL] [Abstract][Full Text] [Related]
5. Identification of a new congenital defect of platelet function characterized by severe impairment of platelet responses to adenosine diphosphate.
Cattaneo M; Lecchi A; Randi AM; McGregor JL; Mannucci PM
Blood; 1992 Dec; 80(11):2787-96. PubMed ID: 1333302
[TBL] [Abstract][Full Text] [Related]
6. Responses of rabbit platelets to adrenaline induced by other agonists.
Hallam TJ; Scrutton MC; Wallis RB
Thromb Res; 1981 Feb 15-Mar 1; 21(4-5):413-24. PubMed ID: 7268693
[No Abstract] [Full Text] [Related]
7. Effect of phorbol 12-myristate 13-acetate (PMA) on agonist-induced arachidonate release and 5-hydroxytryptamine secretion in human platelets. Dependence of effects on agonist type and time of incubation with PMA.
Krishnamurthi S; Joseph S; Kakkar VV
Biochim Biophys Acta; 1987 Mar; 927(3):429-36. PubMed ID: 3101746
[TBL] [Abstract][Full Text] [Related]
8. Disparate effects of the calcium-channel blockers, nifedipine and verapamil, on alpha 2-adrenergic receptors and thromboxane A2-induced aggregation of human platelets.
Johnson GJ; Leis LA; Francis GS
Circulation; 1986 Apr; 73(4):847-54. PubMed ID: 3004784
[TBL] [Abstract][Full Text] [Related]
9. Effects of the P2-purinoceptor antagonist, suramin, on human platelet aggregation induced by adenosine 5'-diphosphate.
Hourani SM; Hall DA; Nieman CJ
Br J Pharmacol; 1992 Feb; 105(2):453-7. PubMed ID: 1559134
[TBL] [Abstract][Full Text] [Related]
10. Benzodiazepines inhibit human platelet activation: comparison of the mechanism of antiplatelet actions of flurazepam and diazepam.
Romstedt K; Huzoor-Akbar
Thromb Res; 1985 May; 38(4):361-74. PubMed ID: 2990062
[TBL] [Abstract][Full Text] [Related]
11. Potentiation of aggregation and inhibition of adenylate cyclase in human platelets by prostaglandin E analogues.
Matthews JS; Jones RL
Br J Pharmacol; 1993 Feb; 108(2):363-9. PubMed ID: 8448586
[TBL] [Abstract][Full Text] [Related]
12. Decrease of platelet aggregation and spreading via inhibition of the cAMP phosphodiesterase by trapidil.
Mazurov AV; Menshikov MYu ; Leytin VL; Tkachuk VA; Repin VS
FEBS Lett; 1984 Jul; 172(2):167-71. PubMed ID: 6086387
[TBL] [Abstract][Full Text] [Related]
13. The cyclic AMP-lowering effect on the stable endoperoxide analog U46619 in human platelets.
Bonne C; Martin B; Regnault F
Thromb Res; 1980 Dec 1-15; 20(5-6):701-4. PubMed ID: 6262941
[No Abstract] [Full Text] [Related]
14. Phenol red is a thromboxane A2/prostaglandin H2 receptor antagonist in canine lingual arteries and human platelets.
Greenberg SS; Johns A; Kleha J; Xie J; Wang Y; Bianchi J; Conley K
J Pharmacol Exp Ther; 1994 Mar; 268(3):1352-61. PubMed ID: 8138950
[TBL] [Abstract][Full Text] [Related]
15. Ca2+ mobilization in blood platelets as visualized by chlortetracycline fluorescence.
Owen NE; Le Breton GC
Am J Physiol; 1981 Oct; 241(4):H613-9. PubMed ID: 6274207
[TBL] [Abstract][Full Text] [Related]
16. Platelet activation induced by a stable analogue of endoperoxides (U46619).
Zatta A; Prosdocimi M
Thromb Haemost; 1989 Apr; 61(2):328-9. PubMed ID: 2526389
[No Abstract] [Full Text] [Related]
17. Inhibition of platelet aggregation by monoclonal antibody reactive with beta 2-microglobulin chain of HLA complex.
Curry RA; Messner RP; Johnson GJ
Science; 1984 May; 224(4648):509-11. PubMed ID: 6324346
[TBL] [Abstract][Full Text] [Related]
18. Potent antiplatelet effects of cyclic clofibric acid (CPIB) analogs on human platelets.
Romstedt KJ; Kim SU; Witiak DT; Newman HA; Feller DR
Thromb Res; 1989 May; 54(4):289-99. PubMed ID: 2503906
[TBL] [Abstract][Full Text] [Related]
19. Removal of extraplatelet Na+ eliminates indomethacin-sensitive secretion from human platelets stimulated by epinephrine, ADP, and thrombin.
Connolly TM; Limbird LE
Proc Natl Acad Sci U S A; 1983 Sep; 80(17):5320-4. PubMed ID: 6577431
[TBL] [Abstract][Full Text] [Related]
20. Role of ADP in platelet aggregation and fibrinogen binding induced by prostaglandin endoperoxides: studies in a patient with a selective defect of ADP-induced platelet aggregation.
Cattaneo M; Randi AM; Canciani MT; Lecchi A; Mannuci PM
Prog Clin Biol Res; 1988; 283():279-83. PubMed ID: 3211954
[No Abstract] [Full Text] [Related]
[Next] [New Search]
